Movano Inc. (MOVE)
Market Cap | 31.76M |
Revenue (ttm) | 852,000 |
Net Income (ttm) | -26.83M |
Shares Out | 98.95M |
EPS (ttm) | -0.41 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 89,703 |
Open | 0.303 |
Previous Close | 0.330 |
Day's Range | 0.303 - 0.338 |
52-Week Range | 0.240 - 1.060 |
Beta | 0.12 |
Analysts | Buy |
Price Target | 2.00 (+523.05%) |
Earnings Date | Nov 13, 2024 |
About MOVE
Movano Inc. engages in developing a platform to deliver healthcare solutions at the intersection of medical and consumer devices. The company is involved in the development of Evie Ring, which is a wearable designed specifically for women that combines health and wellness metrics comprises resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, and menstrual symptom tracking, as well as activity profile, including steps, active minutes and c... [Read more]
Financial Performance
Financial StatementsAnalyst Forecast
According to one analyst, the rating for MOVE stock is "Buy" and the 12-month stock price forecast is $2.0.
News
Movano Health Provides Update on FDA Review of EvieMED Ring
The Company continues to work closely with the FDA to bring this pioneering healthcare product to market PLEASANTON, Calif. , Oct. 10, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) announced toda...
Evie, Movano Health's Smart Ring for Women, is Back In Stock with Key Upgrades
Orders Reopen with Enhancements to AI Powered Health Insights, Sleep and Heart Rate Measurements and More PLEASANTON, Calif. , Sept. 17, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) today announc...
Movano Health Advances to Final Phase of FDA Review Process for EvieMED Ring
Following the positive outcome of a recent agency meeting, the Company will continue to work closely with the FDA to bring this pioneering healthcare product to market PLEASANTON, Calif. , Sept. 3, 20...
Movano Inc. (MOVE) Q2 2024 Earnings Call Transcript
Movano Inc. (NASDAQ:MOVE) Q2 2024 Earnings Conference Call August 14, 2024 5:00 PM ET Company Participants Jay Cogan - CFO John Mastrototaro - CEO Tyla Bucher - Chief Marketing Officer Michael Leabma...
Movano Health Reports Q2 2024 Financial Results and Provides Business Update
Prepares for September 17, 2024, Evie Ring back in stock date Announces brand partnership with digital creator Heidi D'Amelio Focuses on launch of EvieMED and securing B2B opportunities Conference Cal...
Movano Health Provides Progress Update on EvieMED Regulatory Filing
Company continues to work with FDA to bring this pioneering healthcare product to market PLEASANTON, Calif. , Aug. 5, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) plans to meet with the FDA i...
Movano Health to Report Second Quarter 2024 Financial Results on Wednesday August 14, 2024
Conference Call at 2:00 PM PT/ 5:00 PM ET PLEASANTON, Calif. , Aug. 5, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announced that it will report second qua...
Movano Health Announces Dr. Fatima Rodriguez Joining July 11 Virtual Event
Allele Capitals' Matt Hughes will moderate future forward panel on enterprise need in wearables for a variety of healthcare applications PLEASANTON, Calif. , June 28, 2024 /PRNewswire/ -- Movano Healt...
Movano Health Applies Advanced AI through Deep Learning to Deliver Improved Accuracy of Heart Rate in Motion
Enhancements address significant clinical enterprise need in wearables for a variety of healthcare applications PLEASANTON, Calif., June 13, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) announ...
MIT Selects Movano Health for Groundbreaking Study on Long COVID and Chronic Lyme Disease
Pioneering partnership advances innovative health monitoring, setting the stage for future enterprise opportunities. PLEASANTON, Calif.
Movano Inc. (MOVE) Q1 2024 Earnings Call Transcript
Movano Inc. (NASDAQ:MOVE) Q1 2024 Earnings Conference Call May 15, 2024 5:00 PM ET Company Participants John Mastrototaro - Chief Executive Officer Michael Soule - Vice President of Business Developm...
Movano Health Reports Q1 2024 Financial Results and Provides Business Update
Submits exemplary Sp02 clinical trial results as part of FDA 510(k) clearance process Plans launch of Evie Med and focuses on B2B opportunities Plans arterial blood pressure study for June Conference ...
Movano Health Submits Exemplary Sp02 Clinical Trial Results in Key Step Towards FDA 510(k) Clearance Decision
Unlocking business-to-business opportunities with Evie Med, Movano Health's ring pulse oximeter, remains a key priority for the Company. PLEASANTON, Calif.
Movano Health to Report First Quarter 2024 Financial Results on Wednesday May 15, 2024
Conference Call at 2:00 PM PT/ 5:00 PM ET PLEASANTON, Calif., May 6, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announced that it will report first quarte...
Movano Inc. (MOVE) Q4 2023 Earnings Call Transcript
Movano Inc. (NASDAQ:MOVE) Q4 2023 Results Conference Call April 4, 2024 5:00 PM ET Company Participants David Barnard - Senior Vice President of Investor Relations John Mastrototaro - CEO Michael Sou...
Movano Health Closes $24 Million Private Placement
Financing included a strategic seed investment by a tier-1 multi-billion dollar medical device company and participation from insiders including members of Movano Health's management team and board of...
Movano Health Reports 2023 Financial Results and Provides Business Update
Executes $24 million funding extending cash runway Focuses on 2024 strategic pathway to FDA clearances driving B2B opportunities Plans launch of Evie Med Conference Call at 2:00 PM PT/ 5:00 PM ET T...
Movano Health Announces $24 Million Private Placement
Financing included a strategic seed investment by a tier-1 multi-billion dollar medical device company and participation from members of Movano Health's management team and board of directors Hosting ...
Movano Health Secures Strategic Investment from Tier-One Multi-Billion Dollar Medical Device Company
The seed investment and agreement underscores Movano Health's multi-analyte and proprietary mmWave radio frequency technology PLEASANTON, Calif. , April 2, 2024 /PRNewswire/ -- Movano Health (Nasdaq:...
Movano Health to Report Fourth Quarter 2023 Financial Results on Thursday, April 4, 2024
Conference Call at 2:00 PM PT/ 5:00 PM ET PLEASANTON, Calif. , April 2, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announced that it will report fourth qu...
Movano Health Announces Evie Rings Now Shipping
PLEASANTON, Calif. , Jan. 22, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, announced that its female first wearable, the Evie Ring, will begin shipping today.
Movano Health and ams OSRAM Collaborate to Deliver Accurate Lifestyle Monitoring Solutions for Women
LAS VEGAS, Jan. 9, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, and ams OSRAM, a leader in technology for biometric monitoring, have collaborated to include ams O...
Evie, the First Women-Focused Health Ring, Takes 'Smart' to a New Level
Movano Health's 2024 CES Innovation Honoree Ships This Month LAS VEGAS , Jan. 8, 2024 /PRNewswire/ -- The Evie Ring from Movano Health (Nasdaq: MOVE), the market's first women-focused smart ring, is r...
Movano Health Announces HSA/FSA Eligibility for its Women First Wearable, The Evie Ring
PLEASANTON, Calif. , Dec. 18, 2023 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announced that its female first wearable, the Evie Ring, is now eligible for HSA/...
Movano Health Announces Blood Pressure Partnership Forum Following Significant Response to Groundbreaking Accuracy Achievement
PLEASANTON, Calif. , Dec. 12, 2023 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announced that following the successful results of its recent blood pressure clin...